NPORT-EX 2 poi_fhmdtlargecapgrowthfd.htm POI - FEDERATED HERMES MDT LARGE CAP GROWTH FUND F/K/A FEDERATED MDT LARGE CAP GROWTH FUND
Federated MDT Large Cap Growth Fund
Portfolio of Investments
April 30, 2020 (unaudited)
Shares     Value
    COMMON STOCKS—98.3%  
    Communication Services—10.5%  
2,330 1 AMC Networks, Inc. $55,570
6,188 1 Alphabet, Inc., Class A 8,333,380
127   Cable One, Inc. 242,933
3,536 1 Charter Communications, Inc. 1,751,133
3,369 1,2 Discovery, Inc., Class A 75,533
21,665 1 Facebook, Inc. 4,435,042
70,783 1,2 MSG Networks, Inc. 840,902
4,769 1 Netflix, Inc. 2,002,265
33,732 1 TripAdvisor, Inc. 673,628
    TOTAL 18,410,386
    Consumer Discretionary—13.8%  
4,569 1 Amazon.com, Inc. 11,303,706
87,480 1,2 Capri Holdings Ltd. 1,334,070
10,081   Domino's Pizza, Inc. 3,648,616
4,223   eBay, Inc. 168,202
39,345 1 Ford Motor Co. 200,266
9,020 1,2 Fossil, Inc. 35,719
7,018 1,2 GNC Holdings, Inc. 4,039
1,498   Home Depot, Inc. 329,305
7,419   Lowe's Cos., Inc. 777,140
3,249   Nike, Inc., Class B 283,248
98,594 1,2 Norwegian Cruise Line Holdings Ltd. 1,616,942
9,850 1 Six Flags Entertainment Corp. 197,098
10,746   Starbucks Corp. 824,541
68 1 Tesla, Inc. 53,168
14,685 2 Tupperware Brands Corp. 47,286
4,942 1,2 Under Armour, Inc., Class A 51,496
36,816   V.F. Corp. 2,139,010
38,720   Wyndham Destinations, Inc. 990,070
    TOTAL 24,003,922
    Consumer Staples—3.8%  
15,859   Church and Dwight, Inc. 1,109,972
5,148   Clorox Co. 959,793
10,064   Costco Wholesale Corp. 3,049,392
19,190   Flowers Foods, Inc. 427,553
2,310   Hershey Foods Corp. 305,913
589   Kimberly-Clark Corp. 81,565
4,848   PepsiCo, Inc. 641,342
    TOTAL 6,575,530
    Financials—3.9%  
11,363   MSCI, Inc., Class A 3,715,701
1,453   Marketaxess Holdings, Inc. 661,130
2,202   S&P Global, Inc. 644,922
17,557   The Travelers Cos., Inc. 1,776,944
3,575   Waddell & Reed Financial, Inc., Class A 52,016
    TOTAL 6,850,713
1

Shares     Value
    COMMON STOCKS—continued  
    Health Care—14.8%  
12,837   Abbott Laboratories $1,182,159
5,543   AbbVie, Inc. 455,635
11,166 1 Alexion Pharmaceuticals, Inc. 1,200,010
6,672   Amgen, Inc. 1,596,076
932 1 Biogen, Inc. 276,646
731   Cooper Cos., Inc. 209,578
34,435   Eli Lilly & Co. 5,325,028
32,610 1 Hologic, Inc. 1,633,761
2,011 1 IDEXX Laboratories, Inc. 558,254
1,026 1 Jazz Pharmaceuticals PLC 113,116
7,231 1 Masimo Corp. 1,546,783
20,756   Merck & Co., Inc. 1,646,781
605 1 Mettler-Toledo International, Inc. 435,564
2,549 1 Moderna, Inc. 117,228
1,495 1 Molina Healthcare, Inc. 245,135
356 1 Regeneron Pharmaceuticals, Inc. 187,213
5,643   Stryker Corp. 1,052,024
2,161   UnitedHealth Group, Inc. 632,028
3,600 1 Veeva Systems, Inc. 686,880
16,648 1 Vertex Pharmaceuticals, Inc. 4,181,978
276 1 Waters Corp. 51,612
18,835   Zoetis, Inc. 2,435,554
    TOTAL 25,769,043
    Industrials—8.5%  
4,290   Ametek, Inc. 359,802
19,031 2 Flowserve Corp. 536,103
1,454   IDEX Corp. 223,378
296,109   KAR Auction Services, Inc. 4,435,713
9,524   Lockheed Martin Corp. 3,705,408
20,193 1 Middleby Corp. 1,123,337
3,336   Nielsen Holdings PLC 49,139
586   Norfolk Southern Corp. 100,265
44,180 2 Pitney Bowes, Inc. 155,955
6,033 1 R.R. Donnelley & Sons Co. 10,316
92,879   Spirit AeroSystems Holdings, Inc., Class A 2,058,199
13,463 2 Verisk Analytics, Inc. 2,057,550
    TOTAL 14,815,165
    Information Technology—39.5%  
1,876   Accenture PLC 347,416
16,222 1 Adobe, Inc. 5,736,748
18,012   Alliance Data Systems Corp. 901,861
47,815   Apple, Inc. 14,048,047
2,377   Applied Materials, Inc. 118,089
4,991 1 Arista Networks, Inc. 1,094,526
6,030 1 Atlassian Corp. PLC 937,605
577   Automatic Data Processing, Inc. 84,640
1,696 2 Booz Allen Hamilton Holding Corp. 124,554
51,813 1 Cadence Design Systems, Inc. 4,203,589
335   Citrix Systems, Inc. 48,578
9,754   Cognizant Technology Solutions Corp. 565,927
25,892 1 DocuSign, Inc. 2,712,187
2

Shares     Value
    COMMON STOCKS—continued  
    Information Technology—continued  
22,915 1 Dynatrace Holdings LLC $684,013
29,815 1 Fortinet, Inc. 3,212,268
1,745   Henry Jack & Associates, Inc. 285,395
6,449   Intuit, Inc. 1,740,005
21,329 1 Keysight Technologies, Inc. 2,064,007
1,673   Lam Research Corp. 427,083
14,154   Mastercard, Inc. 3,891,925
72,538   Microsoft Corp. 12,999,535
5,449   NVIDIA Corp. 1,592,634
21,875   Paychex, Inc. 1,498,875
13,893 1 PayPal Holdings, Inc. 1,708,839
35,344   Qualcomm, Inc. 2,780,513
4,140 1 RingCentral, Inc. 946,114
121,906 1 Sabre Corp. 886,257
11,216   Skyworks Solutions, Inc. 1,165,118
332 1 Synopsys, Inc. 52,164
636   Universal Display Corp. 95,476
8,389 1 Verisign, Inc. 1,757,412
2,450   Xilinx, Inc. 214,130
    TOTAL 68,925,530
    Materials—0.2%  
467   Avery Dennison Corp. 51,552
2,216   Grace (W.R.) & Co. 104,662
905   Scotts Miracle-Gro Co. 112,247
152   Sherwin-Williams Co. 81,528
    TOTAL 349,989
    Real Estate—3.3%  
4,680   American Tower Corp. 1,113,840
276   Equinix, Inc. 186,355
15,169   SBA Communications, Corp. 4,397,797
    TOTAL 5,697,992
    TOTAL COMMON STOCKS
(IDENTIFIED COST $135,304,405)
171,398,270
    INVESTMENT COMPANIES—3.4%  
3,151,595   Federated Government Obligations Fund, Premier Shares, 0.22%3 3,151,595
2,724,481   Federated Institutional Prime Value Obligations Fund, Institutional Shares, 0.66%3 2,725,571
    TOTAL INVESTMENT COMPANIES
(IDENTIFIED COST $5,874,658)
5,877,166
    TOTAL INVESTMENT IN SECURITIES—101.7%
(IDENTIFIED COST $141,179,063)
177,275,436
    OTHER ASSETS AND LIABILITIES - NET—(1.7)%4 (3,038,332)
    TOTAL NET ASSETS—100% $174,237,104
3

Affiliated holdings are investment companies which are managed by the Adviser or an affiliate of the Adviser. Transactions with affiliated fund holdings during the period ended April 30, 2020, were as follows:
  Federated
Government
Obligations Fund,
Premier Shares*
Federated
Institutional
Prime Value
Obligations Fund,
Institutional Shares
Total
Affiliated
Transactions
Balance of Shares Held 7/31/2019 145,725 2,521,943 2,667,668
Purchases/Additions 16,310,337 28,812,706 45,123,043
Sales/Reductions (13,304,467) (28,610,168) (41,914,635)
Balance of Shares Held 4/30/2020 3,151,595 2,724,481 5,876,076
Value $3,151,595 $2,725,571 $5,877,166
Change in Unrealized Appreciation/Depreciation N/A $1,920 $1,920
Net Realized Gain/(Loss) N/A $(1,511) $(1,511)
Dividend Income $5,261 $27,343 $32,604
* All or a portion of the balance/activity for the fund relates to cash collateral received on securities lending transactions.
1 Non-income-producing security.
2 All or a portion of these securities are temporarily on loan to unaffiliated broker/dealers.
  As of April 30, 2020, securities subject to this type of arrangement and related collateral were as follows:
   
Market Value of
Securities Loaned
Collateral
Received
$2,938,486 $3,151,595
3 7-day net yield.
4 Assets, other than investments in securities, less liabilities.
Note: The categories of investments are shown as a percentage of total net assets at April 30, 2020.
Investment Valuation
In calculating its net asset value (NAV), the Fund generally values investments as follows:
Equity securities listed on an exchange or traded through a regulated market system are valued at their last reported sale price or official closing price in their principal exchange or market.
Shares of other mutual funds or non-exchange-traded investment companies are valued based upon their reported NAVs.
Fixed-income securities are fair valued using price evaluations provided by a pricing service approved by the Fund’s Board of Trustees (the “Trustees”).
Derivative contracts listed on exchanges are valued at their reported settlement or closing price, except that options are valued at the mean of closing bid and asked quotations.
Over-the-counter (OTC) derivative contracts are fair valued using price evaluations provided by a pricing service approved by the Trustees.
For securities that are fair valued in accordance with procedures established by and under the general supervision of the Trustees, certain factors may be considered, such as: the last traded or purchase price of the security, information obtained by contacting the issuer or dealers, analysis of the issuer’s financial statements or other available documents, fundamental analytical data, the nature and duration of restrictions on disposition, the movement of the market in which the security is normally traded, public trading in similar securities or derivative contracts of the issuer or comparable issuers, movement of a relevant index, or other factors including but not limited to industry changes and relevant government actions.
If any price, quotation, price evaluation or other pricing source is not readily available when the NAV is calculated, if the Fund cannot obtain price evaluations from a pricing service or from more than one dealer for an investment within a reasonable period of time as set forth in the Fund’s valuation policies and procedures, or if information furnished by a pricing service, in the opinion of the valuation committee (“Valuation Committee”), is deemed not representative of the fair value of such security, the Fund uses the fair value of the investment determined in accordance with the procedures described below. There can be no assurance that the Fund could obtain the fair value assigned to an investment if it sold the investment at approximately the time at which the Fund determines its NAV per share, and the actual value obtained could be materially different.
Fair Valuation Procedures
The Trustees have ultimate responsibility for determining the fair value of investments for which market quotations are not readily available. The Trustees have appointed a Valuation Committee comprised of officers of the Fund, Federated MDTA LLC (the “Adviser”) and certain of the Adviser’s affiliated companies to assist in determining fair value and in overseeing the calculation of the NAV. The Trustees have also authorized the use of pricing services recommended by the Valuation Committee to provide fair value evaluations of the current value of certain investments for purposes of calculating the NAV. The Valuation Committee employs various methods for reviewing third-party pricing-service evaluations including periodic reviews of third-party pricing services’ policies, procedures and
4

valuation methods (including key inputs, methods, models and assumptions), transactional back-testing, comparisons of evaluations of different pricing services, and review of price challenges by the Adviser based on recent market activity. In the event that market quotations and price evaluations are not available for an investment, the Valuation Committee determines the fair value of the investment in accordance with procedures adopted by the Trustees. The Trustees periodically review and approve the fair valuations made by the Valuation Committee and any changes made to the procedures.
Factors considered by pricing services in evaluating an investment include the yields or prices of investments of comparable quality, coupon, maturity, call rights and other potential prepayments, terms and type, reported transactions, indications as to values from dealers and general market conditions. Some pricing services provide a single price evaluation reflecting the bid-side of the market for an investment (a “bid” evaluation). Other pricing services offer both bid evaluations and price evaluations indicative of a price between the prices bid and asked for the investment (a “mid” evaluation). The Fund normally uses bid evaluations for any U.S. Treasury and Agency securities, mortgage-backed securities and municipal securities. The Fund normally uses mid evaluations for any other types of fixed-income securities and any OTC derivative contracts. In the event that market quotations and price evaluations are not available for an investment, the fair value of the investment is determined in accordance with procedures adopted by the Trustees.
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in the three broad levels listed below:
Level 1—quoted prices in active markets for identical securities.
Level 2—other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). Also includes securities valued at amortized cost.
Level 3—significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
As of April 30, 2020, all investments of the Fund utilized Level 1 inputs in valuing the Fund’s assets carried at fair value.
5